Bronchogen Peptide Therapy
Benefits, Side Effects, Cost & Protocols
Bronchogen (Ala-Glu-Asp) is a short bioregulatory peptide targeting bronchial and lung tissue. Part of the Khavinson bioregulator peptide series, it is studied for its potential to normalize respiratory tract function and support lung health.
Clinically Reviewed
Reviewed by Alex Evans, PharmD, MBA · Updated May 2026
Evidence-Based
Sourced from FDA, PubMed & ClinicalTrials.gov · View sources
Who Is Bronchogen Best For?
How Bronchogen Works
Short bioregulator peptide that interacts with DNA promoter regions in bronchial epithelial cells, potentially modulating gene expression related to mucosal defense and tissue repair.
Bronchogen FAQ
What is BRONCHOGEN?
Bronchogen is a Khavinson bioregulator tripeptide (Ala-Glu-Asp) researched for bronchial and respiratory tissue support, particularly in age-related respiratory decline.
How does BRONCHOGEN work?
Short bioregulator peptide that interacts with DNA promoter regions in bronchial epithelial cells, potentially modulating gene expression related to mucosal defense and tissue repair.
Is BRONCHOGEN legal to buy?
BRONCHOGEN is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy BRONCHOGEN?
BRONCHOGEN is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does BRONCHOGEN belong to?
BRONCHOGEN is primarily classified as a tissue repair & healing peptide. Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.
What are the research benefits of BRONCHOGEN?
BRONCHOGEN has been studied for: Bronchial tissue support, Respiratory function, Mucosal health, Age-related lung support. Khavinson bioregulator; respiratory/bronchial tissue focus.
Key Studies
12 total on PubMed7 human trials[ANTIINFLAMMATORY AND REGENERATIVE EFFECT OF PEPTIDE THERAPY IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY]
Titova ON, Kuzubova NA, Lebedeva ES et al
Ross Fiziol Zh Im I M Sechenova · Ross Fiziol Zh Im I M SechenovaAnimal
Bronchogen peptide reduced lung inflammation and restored bronchial epithelium structure in COPD model
Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology
Kuzubova NA, Lebedeva ES, Dvorakovskaya IV et al
Bull Exp Biol Med · Bull Exp Biol MedAnimal
Tetrapeptide Bronchogen restored bronchial epithelium structure and reduced inflammation in COPD rats
Short Exogenous Peptides Regulate Expression of CLE, KNOX1, and GRF Family Genes in Nicotiana tabacum
Fedoreyeva LI, Dilovarova TA, Ashapkin VV et al
In Vitro · Biochemistry (Mosc)
Exogenous peptides regulate growth and differentiation genes in tobacco callus cultures
Peptides tissue-specifically stimulate cell differentiation during their aging
Bronchogen News
News aggregated via Google News. Inclusion does not imply endorsement.
Ready to explore Bronchogen with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in Bronchogen.
Take the Quiz →